News | October 30, 2025
Allergan Aesthetics and Girls inspire the next generation of women leaders in STEM
Allergan Aesthetics reaffirms commitment to empowering girls through STEM mentorship and education initiatives
Allergan Aesthetics reaffirms commitment to empowering girls through STEM mentorship and education initiatives
Results demonstrate favorable safety profile and clinically meaningful improvements in patients with non-ischemic heart failure
The antibody was designed and developed at Abzena’s Cambridge, UK,
Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose
Bioconjugation capability to complement commercial payload, linker, and monoclonal antibody services
The product is indicated for the chronic management of patients with Urea Cycle Disorders
Indegene is strengthening its Consulting Practice to help life sciences organizations address their most pressing challenges with speed, impact, and accountability
IKS Health's innovative solution orchestrates a roll out of critical operations functions into a unified and efficient connected workflow
Accelerating hit-to-lead timelines, and strengthening end-to-end drug discovery and development services
Several technologies for hemoglobinopathies are being transferred to commercial partners
Subscribe To Our Newsletter & Stay Updated
